PAS as the main effector of A
Niedobr nawet jednego z tych skadnikw powoduje zmniejszenie wytwarzania l-karnityny
Alongside this, researchers and pharmaceutical companies are accelerating development of dual- and triple-agonist candidates that combine GLP-1 effects with other hormone pathways, aiming to treat diabetes, obesity, and liver or kidney complications with a single medicine, thus marking a clear trend toward integrated metabolic-syndrome therapy
Novel delivery systems: Explore novel delivery systems such as liposomes and nanoparticles to enhance the retention time of polypeptides in the skin and improve their therapeutic effects
usage de recherche uniquement ne pas utiliser chez l'homme ou chez les animaux
The HLA association in celiac disease can be explained by a superior ability of DQ2 to bind the repertoire of proline-rich gluten peptides that have survived gastrointestinal digestion and that have been deaminated by tissue transglutaminase (Kim et al., 2004)